The discovery and development of new drugs is a highly technical process with its own jargon. Even an experienced translator with a scientific background can have difficulty in understanding this jargon and its correct usage in the pharmaceutical and biotechnology industries.
This webinar focuses on some key areas of interest to pharmaceutical translators, including biological drugs that translators will increasingly encounter in regulatory documentation.
What Will You Learn?
- Nomenclature used in drug development
- Clinical trials and regulatory affairs
- New biological drugs entering the market
About the Presenter
Dr. Ed Zanders is the founder and managing director of PharmaGuide, a consulting group offering ” How the Drug Discovery Industry Works” courses to a range of clients, from professionals with no scientific background to PhD level scientists. The firm also provides training and coaching in scientific presentation skills.
Ed has over twenty-five years’ experience in research in biochemistry and related sciences, including sixteen years as a senior scientist and research manager at Glaxo, where he specialized in drug discovery research for inflammatory diseases.
As a trainer, Ed draws on his experiences not only to provide informed content, but also to communicate technical material to specialists and non-specialists alike.
Code of Conduct
ATA is committed to providing a safe, productive, and welcoming environment for all participants. By registering for this event, you agree to abide by the Code of Conduct for Virtual Programs.